Clinical Trial Update: Explore the Short- and Mid-term Effects of Fespixon in Scar Cosmesis Following Cervical or Abdominal Surgery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating short- and mid-term effects of Fespixon on scar cosmesis after cervical or abdominal surgery; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scar

Drugs mentioned

• Fespixon

Snippet

Sponsor: National Defense Medical Center, Taiwan | Conditions: Scar | Phase 4 | Status: COMPLETED